Population Size Estimation of Tramadol Misusers in Urban Population in Iran: Synthesis of Methods and Results

سال انتشار: 1398
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 77

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_AHJK-11-3_005

تاریخ نمایه سازی: 9 مرداد 1403

چکیده مقاله:

Background: Estimating the population who use drugs is essential for planning, monitoring, and evaluation of substance use prevention and treatment. This study aims to estimate the population who misuse tramadol in urban population in Iran. Methods: We used the wisdom of the experts (WOTE) and network scale-up (NSU) methods to calculate the population of tramadol misusers in ۱۰ provincial capitals of Iran, in ۲۰۱۶. The WOTE was conducted among pharmacists in drugstores and the personnel of traditional medicinal herbs stores. They guessed the best estimation of tramadol misusers population in their cities. The NSU method was conducted among the general population and participants were questioned about ever and daily, non-medical use of tramadol during last ۱۲ months in their network. The median of the methods was used to calculate the proportion of the adult population (۱۵-۴۹ years old). Findings: The population size of tramadol misusers in studied cities was ۸۳۳۰۰ [۹۵% uncertainty limits (UL): ۴۷۹۶۰-۲۵۶۲۲۰]. This corresponded to ۶.۶ per ۱۰۰۰ (۹۵% UL: ۳.۸۸-۲۰.۳۰) of the ۱۵-۴۹-year-old population. The projected number of tramadol misusers for all ۳۱ provincial capitals was ۱۱۸۲۹۰ (۹۵% UL: ۶۸۱۰۰-۳۶۳۱۳۰۸۴۰) and ۲۱۲۴۴۰ (۹۵% UL: ۱۲۲۳۱۰-۶۵۳۴۱۰) for all urban areas. NSU also estimated the number of people who misuse tramadol on daily basis. These numbers were ۵۲۰۰۰ (۹۵% UL: ۱۹۹۴۰-۱۷۶۵۷۰) for studied cities, ۷۳۸۴۰ (۹۵% UL: ۲۸۳۲۰-۲۵۰۷۴۰) for all ۳۱ provincial capital cities, and ۱۳۲۶۱۰ (۹۵% UL: ۵۰۸۶۰-۴۵۰۳۱۰) for all urban areas in Iran. Conclusion: This study presents information on high prevalence of tramadol misuse in urban population. We need national control measures and demand reduction programs to control tramadol misuse.

کلیدواژه ها:

نویسندگان

Naser Nasiri

Department of Public Health, School of Public Health, Jiroft University of Medical Sciences, Jiroft, Iran

Leili Abedi

HIV/STI Surveillance Research Center and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Ahmad Hajebi

Research Center for Addiction and Risky Behaviors AND Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Alireza Noroozi

Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine AND Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran

Malahat Khalili

HIV/STI Surveillance Research Center and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Maryam Chegeni

HIV/STI Surveillance Research Center and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Sairan Nili

Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Moslem Taheri-Soodejani

Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Mehdi Noroozi

Social Determinants of Health Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Armita Shahesmaili

HIV/STI Surveillance Research Center and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Forouzanfar MH, Sepanlou SG, Shahraz S, Dicker D, Naghavi P, ...
  • Khazaee-Pool M, Moeeni M, Ponnet K, Fallahi A, Jahangiri L, ...
  • Radbruch L, Grond S, Lehmann KA. A risk-benefit assessment of ...
  • Tjaderborn M, Jonsson AK, Hagg S, Ahlner J. Fatal unintentional ...
  • Afshari R, Ghooshkhanehee H. Tramadol overdose induced seizure, dramatic rise ...
  • Leppert W. Tramadol as an analgesic for mild to moderate ...
  • Deilamizade A, Esmizade S. Economic sanctions against Iran, and drug ...
  • Salehi-Isfahani D. Iranian youth in times of economic crisis. Iran ...
  • Momtazi S, Rawson R. Substance abuse among Iranian high school ...
  • Fawzi MM. Some medicolegal aspects concerning tramadol abuse: The new ...
  • Bassiony MM, Salah El-Deen GM, Yousef U, Raya Y, Abdel-Ghani ...
  • Sheikholeslami B, Jamali B, Rouini M. Tramadol,usage, misuse, and addiction ...
  • Dhesi M, Maani CV. Tramadol. Treasure Island, FL: StatPearls Publishing; ...
  • Bassiony MM, Youssef UM, Hassan MS, Salah El-Deen GM, El-Gohari ...
  • Nazarzadeh M, Bidel Z, Carson KV. The association between tramadol ...
  • Agrawal A, Grant JD, Waldron M, Duncan AE, Scherrer JF, ...
  • Lee MD, Zhang S, Shi J. The wisdom of the ...
  • Okal J, Geibel S, Muraguri N, Musyoki H, Tun W, ...
  • Bernard HR, Hallett T, Iovita A, Johnsen EC, Lyerla R, ...
  • Johnsen EC, Bernard HR, Killworth PD, Shelley GA, McCarty C. ...
  • Addict Health, Summer ۲۰۱۹; Vol ۱۱, No ۱ ۱۸۱http://ahj.kmu.ac.ir, ۰۶ ...
  • Rastegari A, Haji-Maghsoudi S, Haghdoost A, Shatti M, Tarjoman T, ...
  • Sharifi H, Karamouzian M, Baneshi MR, Shokoohi M, Haghdoost A, ...
  • Bashirian S, Barati M, Fathi Y. Prevalence and factors associated ...
  • Ansari-Moghaddam A, Rakhshani F, Shahraki-Sanavi F, Mohammadi M, Miri-Bonjar M, ...
  • Xu JJ, Zhang C, Hu QH, Chu ZX, Zhang J, ...
  • Alinejad S, Zamani N, Abdollahi M, Mehrpour O. A narrative ...
  • Zabihi E, Hoseinzaadeh A, Emami M, Mardani M, Mahmoud B, ...
  • Pourmohammadi B, Jalilvand MA. Tramadol abuse and its related factors ...
  • Bassiony MM, Abdelghani M, Salah El-Deen GM, Hassan MS, El-Gohari ...
  • Nazarzadeh M, Bidel Z, Ayubi E, Bahrami A, Jafari F, ...
  • Eassa BI, El-Shazly MA. Safety and efficacy of tramadol hydrochloride ...
  • Abood EA, Wazaify M. Abuse and misuse of prescription and ...
  • Javadi M, Ashrafi N, Salari P. Assessment of pharmacists experiences ...
  • نمایش کامل مراجع